Christopher T. Cox, EVP & Chief Corporate Development Officer at MEDICINES CO /DE (MDCO), bought 91,970 shares at $38.43 ($3.5M) on 2016-06-08, disclosed to the SEC on 2016-06-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.43 | 25,975 | $998K | 28.6% |
| 2 | $38.43 | 25,975 | $998K | 28.6% |
| 3 | $37.21 | 6,670 | $248K | 7.1% |
| 4 | $37.21 | 6,670 | $248K | 7.1% |
| 5 | $37.22 | 13,340 | $497K | 14.2% |
| 6 | $37.22 | 13,340 |
| $497K |
| 14.2% |
| Total | $37.90 avg | 91,970 | $3.5M | 100% |
| Filing → |
| MDCO | BUY | 2018-11-19 | $992K | — | Filing → |
| MDCO | BUY | 2016-12-09 | $3.5M | — | Filing → |
| MDCO | BUY | 2016-06-08 | $3.8M | — | Filing → |